The withdrawal of Redux (dexfenfluramine) and Pondimin (fenfluramine) leaves lots of unanswered questions

    The withdrawal of Redux (dexfenfluramine) and Pondimin (fenfluramine) leaves lots of unanswered questions.

    How many patients might have heart valve problems...who should get an ECHO...and whether these problems are reversible.

    Researchers now suggest that 30% of patients on Redux or Pondimin might have leaky heart valves.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote